This is a preview of subscription content, log in via an institution to check access.
Reference
Carter L, et al. An emerging role of interferon-targeted therapy for the treatment of cutaneous systemic lupus erythematosus: A prospective real-world evaluation of anifrolumab for refractory cutaneous lupus. British Journal of Dermatology 188 (Suppl. 4): iv88 abstr. P41, Jun 2023. Available from: URL: http://doi.org/10.1093/bjd/ljad113.184 [abstract]
Rights and permissions
About this article
Cite this article
Anifrolumab/prednisolone. Reactions Weekly 1971, 26 (2023). https://doi.org/10.1007/s40278-023-45151-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-45151-0